Biosergen AB (OSTO:BIOSGN) Short Interest

View and export this data going back to 2021. Start your Free Trial

What is Biosergen AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Biosergen AB's Short Interest

For the Biotechnology subindustry, Biosergen AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biosergen AB's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosergen AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Biosergen AB's Short Interest falls into.

Save Embed

;

Save Embed

;

Biosergen AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosergen AB (OSTO:BIOSGN) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

N/A

Address

Fogdevreten 2, Solna, SWE, 17165

Website

https://www.biosergen.net

Biosergen AB is a biotech company developing innovative antifungal drugs based on latest biopharmaceutical research and development from laboratory facilities in Trondheim, Norway, and several other places worldwide. The company is developing BSG005, a potentially disruptive antifungal drug, which has demonstrated significant safety and potency advantages over competing antifungals.

Biosergen AB Headlines

No Headlines